Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Laserscope Gets FDA Clearance for Pseudo-Folliculitis

Facebook Twitter LinkedIn Email Comments
SAN JOSE, Calif., Feb. 16 -- Laserscope has received clearance from the US Food and Drug Administration to market its Lyra long-pulse Nd:YAG laser system for the treatment of pseudo folliculitis, which is the inflammation or superficial infection of the hair follicle. It is often the result of injury or damage to the hair follicle caused by shaving or friction from clothing. Pseudofolliculitis barbae, commonly referred to as shaving bumps, razor bumps or ingrown hairs, is a condition occurring primarily in men and women of African or Middle Eastern descent.
    "We are very excited to be the first and only company to have been granted marketing clearance by the FDA for the treatment of PFB," said Eric Reuter, Laserscope president and CEO. "We believe our clinical results are unmatched by any other technology or treatment modality currently available and having FDA clearance to market for this indication adds another potent application to this multispecialty laser system. Since there are no other known effective ways to address this condition, we believe that many people who suffer from it will seek treatment when they are made aware that it is available."

Photonics.com
Feb 2001
News & Featureslasers

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.